Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis

IntroductionPrior studies have established altered microbiota and immunologic reactivity to enteric commensal organisms in inflammatory bowel disease (IBD). Since intestinal inflammation is present in a subset of patients with both pediatric and adult spondyloarthritis (SpA), we hypothesized that SpA patients may also have altered microbiota and immune responsiveness to enteric organisms.MethodsStool and blood specimens were collected from children with enthesitis-related arthritis (ERA) and non-inflammatory controls. DNA purified from stool was subject to PCR amplification and sequencing of the variable IV region from the 16S rDNA gene. IgA and IgG Enzyme-linked Immunosorbent Assays (ELISAs) were performed on select species of bacteria in most subjects.ResultsTwenty-five children with ERA and 13 controls were included. The ERA patients had less Faecalibacterium prausnitzii (3.8% versus 10%, P = 0.008) and lachnospiraceae family (12 versus 7.0%, P = 0.020), a statistically significant increase in bifidobacterium (1.8% versus 0%, P = 0.032) and a non-statistically significant increase in Bacteroides (21% versus 11%, P = 0.150). Akkermansia muciniphila was abundant (>2%) in 7/27 ERA patients but none of the controls (P = 0.072.) Cluster analysis revealed two clusters of ERA patients: Cluster one (n = 8) was characterized by high levels of Bacteroides genus, while a second (n = 15) cluster had similar levels as the controls. Seven of 17 (41%) of the ERA subjects in Cluster 2 compared to 0/8 of the subjects in Cluster 1 had abundant Akkermansia muciniphila (P = 0.057). Serum IgA and IgG antibody levels against F. prausnitzii and B. fragilis were similar between patients and controls, whereas the two groups showed divergent responses when the fecal relative abundances of F. prausnitzii and Bacteroides were compared individually against IgA antibody levels recognizing F. prausnitzii and B. fragilis, respectively.ConclusionThe abundance of F. prausnitzii in the stool among patients with ERA is reduced compared to controls, and Bacteroides and A. muciniphila are identified as associative agents in subsets of ERA patients. Differences in the humoral responses to these bacteria may contribute to disease.

[1]  W. D. de Vos,et al.  Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. , 2004, International journal of systematic and evolutionary microbiology.

[2]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[3]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[4]  Rob Knight,et al.  PyNAST: a flexible tool for aligning sequences to a template alignment , 2009, Bioinform..

[5]  S. Targan,et al.  Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study , 2013, Arthritis Research & Therapy.

[6]  J. Čapková,et al.  Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. , 2008, Human immunology.

[7]  F. Pallone,et al.  Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. , 2009, World journal of gastroenterology.

[8]  R. Hammer,et al.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.

[9]  J. Doré,et al.  Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. , 2002, Rheumatology.

[10]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[11]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.

[12]  D. Faith,et al.  Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges , 2006, Evolutionary bioinformatics online.

[13]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[14]  H. Flint,et al.  Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. , 2010, Environmental microbiology.

[15]  H. Flint,et al.  Oligonucleotide Probes That Detect Quantitatively Significant Groups of Butyrate-Producing Bacteria in Human Feces , 2003, Applied and Environmental Microbiology.

[16]  R. Knight,et al.  UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.

[17]  C. Elson,et al.  Host-microbiota interactions in inflammatory bowel disease , 2012, Gut microbes.

[18]  N. Pace,et al.  Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[19]  S. Targan,et al.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.

[20]  Seppo Salminen,et al.  The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal Tract , 2007, Applied and Environmental Microbiology.

[21]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[22]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[23]  J. Rosenbaum,et al.  Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. , 2011, Arthritis and rheumatism.

[24]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[25]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[26]  J. Neu.  The Human Microbiome and Its Potential Importance to Pediatrics , 2012 .

[27]  R. Klopfleisch,et al.  Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice , 2013, PloS one.

[28]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[29]  C. Langefeld,et al.  FcαRI (CD89) Alleles Determine the Proinflammatory Potential of Serum IgA1 , 2007, The Journal of Immunology.

[30]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[31]  G. Magri,et al.  Intestinal IgA production and its role in host‐microbe interaction , 2014, Immunological reviews.

[32]  W. D. de Vos,et al.  Contribution of the intestinal microbiota to human health: from birth to 100 years of age. , 2013, Current topics in microbiology and immunology.

[33]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[34]  M. Vatn,et al.  Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients , 2013, Gastroenterology research and practice.

[35]  William A. Walters,et al.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.

[36]  G. Macfarlane,et al.  Longitudinal Analyses of Gut Mucosal Microbiotas in Ulcerative Colitis in Relation to Patient Age and Disease Severity and Duration , 2012, Journal of Clinical Microbiology.

[37]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[38]  E. Blair,et al.  NEW TRANSPORT MEDIUM FOR SHIPMENT OF CLINICAL SPECIMENS I , 1964, Journal of bacteriology.

[39]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.

[40]  G. Macpherson,et al.  Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. , 1995, Immunology.

[41]  Atlanta,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.

[42]  S. Ng,et al.  Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease , 2012, Inflammatory bowel diseases.

[43]  J. Highton,et al.  The Immune Response to Autologous Bacteroides in Ankylosing Spondylitis Is Characterized by Reduced Interleukin 10 Production , 2009, The Journal of Rheumatology.

[44]  K. McCoy,et al.  The immune geography of IgA induction and function , 2008, Mucosal Immunology.

[45]  J. Reveille.  The genetic basis of spondyloarthritis , 2011, Annals of the rheumatic diseases.

[46]  J. Silva,et al.  Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. , 2000, Emerging infectious diseases.

[47]  James Versalovic,et al.  The Human Microbiome and Its Potential Importance to Pediatrics , 2012, Pediatrics.

[48]  C. Huttenhower,et al.  Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis , 2013, eLife.

[49]  박주홍,et al.  The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .

[50]  C. Langefeld,et al.  FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA. , 2007, Journal of immunology.

[51]  J. Reveille,et al.  Genetics of spondyloarthritis—beyond the MHC , 2012, Nature Reviews Rheumatology.

[52]  J. Jarvis,et al.  Identifying children with chronic arthritis based on chief complaints: absence of predictive value for musculoskeletal pain as an indicator of rheumatic disease in children. , 2002, Pediatrics.

[53]  Bing Xia,et al.  Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease , 2013, Journal of Clinical Microbiology.

[54]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.